0001612502-14-000001.txt : 20140709 0001612502-14-000001.hdr.sgml : 20140709 20140709162628 ACCESSION NUMBER: 0001612502-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20140709 DATE AS OF CHANGE: 20140709 EFFECTIVENESS DATE: 20140709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Symbiomix Therapeutics, LLC CENTRAL INDEX KEY: 0001612502 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-220646 FILM NUMBER: 14967536 BUSINESS ADDRESS: STREET 1: 105 LOCK STREET SUITE 409 CITY: NEWARK STATE: NJ ZIP: 07103 BUSINESS PHONE: 609-722-7250 MAIL ADDRESS: STREET 1: 105 LOCK STREET SUITE 409 CITY: NEWARK STATE: NJ ZIP: 07103 D 1 primary_doc.xml X0707 D LIVE 0001612502 Symbiomix Therapeutics, LLC 105 LOCK STREET SUITE 409 NEWARK NJ NEW JERSEY 07103 609-722-7250 DELAWARE None None Limited Liability Company true 2012 Robert Jacks 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Executive Officer Director Klaus Veitinger 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Rishi Gupta 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Thomas Beck 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Pharmaceuticals Decline to Disclose 06c false 2013-05-03 false true false 0 32545389 19545389 13000000 false 5 0 0 0 false Symbiomix Therapeutics, LLC /s/ Robert Jacks Robert Jacks Chief Financial Officer and Secretary 2014-07-09